NOVANTA INC (NOVT) Form 10-Q — Aug 5, 2026
Novanta reported Q2 2026 revenue of $265.8 million, up 10.3% year over year, with net income of $12.5 million versus $4.5 million a year earlier. Diluted EPS rose to $0.30 from $0.12, led by Automation Enabling Technologies segment growth of 12.0% and Medical Solutions growth of 8.6%. For the first six months of 2026, revenue reached $523.5 million (up 10.3%) and operating cash flow more than doubled to $116.5 million from $46.8 million, lifting cash and equivalents to $718.7 million. Six-month operating income nonetheless slipped 3.7% to $45.6 million as SG&A and restructuring/acquisition costs climbed.
Key figures
- Eps
- 0.3
- Revenue
- 265807000
- Net Income
- 12541000
- Revenue Yoy
- 10.3%
- Total Assets
- 2139565000
- Cash Position
- 718650000
- Deal Value Usd
- 1200000000
- Basic Eps Q2
- 0.31
- Gross Profit Q2
- 120915000
- Six Month Revenue
- 523514000
- Operating Income Q2
- 18061000
- Six Month Net Income
- 33640000
- Prior Year Q2 Revenue
- 241049000
- Six Month Diluted Eps
- 0.82
- Contract Liabilities
- 48000000
- Segment Revenue AETQ2
- 136215000
- Operating Income Q2 Yoy
- 21.1%
- Prior Year Q2 Net Income
- 4497000
- Riverpoint Debt Funding
- 616000000
- Six Month Revenue Growth
- 10.3%
- Private Placement Shares
- 2142857
- Segment Revenue AETQ2 Yoy
- 12.0%
- Segment Revenue Medical Q2
- 129592000
- Six Month Operating Income
- 45600000
- Effective Tax Rate Six Months
- 20.4%
- Operating Cash Flow Six Months
- 116540000
- Riverpoint Milestone Payment
- 250000000
- Segment Revenue Medical Q2 Yoy
- 8.6%
- Six Month Operating Income Yoy
- -3.7%
- Private Placement Net Proceeds
- 287600000
- Private Placement Gross Proceeds
- 300000000
- Private Placement Price Per Share
- 140
- Remaining Buyback Authorization
- 191600000
- Delayed Draw Term Loan Commitments
- 200000000
- Private Placement Ownership Percent
- 5.7%
- Tangible Equity Units Aggregate Nov2025
- 632500000
Price after filing
Close on the filing date to close N calendar days later (from $148.34). Historical, not a forecast.
AI analysis
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.